While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two ...

The stock market's only certainty is its cyclical nature: long-term overperformance eventually leads to underperformance, and ...

Q2 sales +50% as iDose TR & Epioxa drive 85% gross margin; 2026 guide raised. Read here for a detailed investment analysis.

The Roundhill Memory ETF offers diversified exposure to the memory chip sector and key beneficiaries of the AI-driven memory ...

The yield on the 10-year note finished October 9, 2026 at 5.24%, while the 2-year note ended at 4.80%. The chart below ...

The University of Michigan Consumer Sentiment Index preliminary reading fell to 46.3 in October, a 3.7% decrease from ...

Humana surged after its main Medicare Advantage contract regained a 4-star CMS rating for 2027, a major profit catalyst. Read ...

The Vanguard S&P 500 Growth ETF offers S&P 500 growth exposure but lags QQQ long-term. Click for a detailed look at VOOG.

Teva stock is a "Hold" as its "Pivot to Growth" strategy shows early promise but requires further execution. Click for more ...

Shares of T-Mobile US ( TMUS ), a wireless communications and broadband provider, retreated more than 13% on Friday amid ...

Realty Income is rated Hold, as it trades at 1.30x book value, 24% below peers, making the valuations undemanding. Click for ...

Palantir (PLTR) is executing an aggressive upward-guidance cycle, with FY26 revenue growth now projected at 82% YoY, up from ...